Stocks of companies that make diagnostic health products have had a strong run, and with increased demand and plenty of money for R&D, more gains could be on the way.
Stocks of companies that make diagnostic health products have had a strong run, and with increased demand and plenty of money for R&D, more gains could be on the way.